glp-1 prescriptions growth slowdown 2024 prescription trends through June GLP-1 Prescriptions Quadruple Since 2021

This marked a turning point, shifting GLP-1 agonists from diabetes-focused therapies to primary obesity treatments

Progress has also been made using small molecules that target the peroxisome proliferator-activated receptors (PPAR, PPAR and PPAR (PPAR//)), a family of nuclear-acting receptors, which upon activation, improve systemic glucose and lipid metabolism 10,11

It clumps

Slow Hair Growth: The rate of new hair growth may be affected while on GLP-1 inhibitors

X-rays, 3D imaging, and airway analysis can pick up recessed mandibles, narrow arches, condylar asymmetries, and airway problems that were always there but were hiding under soft tissue